Ortho-Clinical Diagnostics

Type: Company
Name: Ortho-Clinical Diagnostics
First reported 9 hours ago - Updated 9 hours ago - 1 reports

JNJ Beats Estimates, Device Sales Flat

The common stock of healthcare and medical device giant Johnson & Johnson (JNJ) soared to recent highs following the company's announcement of first quarter results that beat analysts' estimates.The company's robust performance was driven by new and existing ... [Published QMED - 9 hours ago]
First reported Apr 15 2014 - Updated 20 hours ago - 1 reports

Flat sales mask busy quarter for J&J med tech biz

At $7.1 billion in revenue, the balance sheet shows no changes in quarterly sales at Johnson & Johnson's ($JNJ) medical devices and diagnostics division, but the unit experienced shifts of other sorts during the first quarter of 2014.For starters, J&J ... [Published FierceMedicalDevices - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Brazil IVD Market Analysis to 2017 - The 5th Largest in the World

Research and Markets (http://www.researchandmarkets.com/research/3lw7rm/the_ivd_market_in) has announced the addition of the "The IVD Market in Brazil" report to their offering. Brazil's in vitro diagnostic test market economic growth exceeded 1 billion ... [Published Individual.com - Apr 15 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Was Selling Ortho-Clinical Diagnostics A Right Move For Johnson & Johnson?

By Trefis :Johnson & Johnson's ( JNJ ) image is undergoing a transformation as its pharmaceuticals business is becoming more significant. The company has traditionally been known for its medical devices and diagnostics equipment, but that is slowly changing. ... [Published BioPortfolio - Apr 04 2014]
First reported Apr 02 2014 - Updated Apr 03 2014 - 3 reports

Is Dividend Machine Johnson & Johnson A Buy?

Medical and consumer products giant Johnson & Johnson (JNJ) made a big splash this week by agreeing to sell is Ortho-Clinical Diagnostics business to The Carlyle Group (CG). The diagnostics business, which JNJ founded in 1937, makes blood tests that screen ... [Published Citybizlist - Apr 03 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Recent Study: Ortho-Clinical Diagnostics Inc. - Strategic SWOT Analysis Review

(live-PR.com) - Ortho-Clinical Diagnostics Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information ... [Published Live-PR.com - Apr 02 2014]
First reported Apr 01 2014 - Updated Apr 02 2014 - 4 reports

J&J accepts binding offer from Carlyle Group for diagnostic unit

Johnson & Johnson has accepted the binding offer from The Carlyle Group, which was received and announced on January 16, 2014, to acquire its Ortho-Clinical Diagnostics business for approximately $4bn, subject to customary adjustments.This acceptance ... [Published Medical Devices Business Review - Apr 02 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

Cramer: JNJ Deal Will Lead to a Buyback and Much More Upside

Johnson & Johnson is selling its Ortho-Clinical Diagnostics business to The Carlyle Group for $4 billion. Jim Cramer, who discussed J&J as a potential breakup candidate in his latest book, 'Get Rich Carefully,' says he believes the money from this shttp://www.firstcoastnews.com/video/3418139845001/1/Cramer-JNJ-Deal-Will-Lead-to-a-Buyback-and-Much-More-Upside ... [Published First Coast News - Apr 01 2014]
First reported Mar 31 2014 - Updated Apr 01 2014 - 16 reports

J&J accepts $4 billion offer for Ortho Clinical Diagnostics

Rochester Business JournalJohnson & Johnson has accepted a roughly $4 billion offer for Ortho Clinical Diagnostics from the Carlyle Group, officials said Monday.The news comes on the day the private-equity group’s Jan. 16 binding offer to buy Ortho Clinical ... [Published Rochester Business Journal - Apr 01 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 1 reports

Benzinga's M&A Chatter for Monday March 31, 2014

The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday March 31, 2014:Johnson & Johnson Accepts $4B Binding Offer from Carlyle Group to Acquire Ortho-Clinical DiagnosticsThe Deal:Johnson & Johnson (NYSE: JNJ) announced ... [Published Benzinga.com - Mar 31 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 2 reports

Wall Street upbeat on the back of Yellen's comments

12:17 pm by Fed Chair Janet Yellen said that the economy still needs extraordinary support for quite some time, which essentially means exceptionally low policy rates as she also said that recovery aid "need not grow as quickly". She spoke at a community ... [Published Proactive Investors USA - Mar 31 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 1 reports

Stocks Open Higher, Heading for Quarterly Gain

Stocks are opening higher on Wall Street as the market heads for a fifth straight quarterly gain.The Standard & Poor's 500 index rose 11 points, or 0.6 percent, to 1,868 in the first few minutes of trading. The index is up 1.1 percent for the first quarter ... [Published ABC News - Mar 31 2014]

Quotes

...54, representing increases of 7.8% and 6.9%, respectively, as compared to the same period in 2013.* "Johnson & Johnson delivered strong first-quarter results driven by successful new product launches and the continued growth of key products" said Alex Gorsky, Chairman and Chief Executive Officer
"The market is really anxious to see more of these larger deals, and new-money deals come to the market" a loan banker said
ReportsnReports.com adds report "2014 Strategies for the Japanese" Clinical Chemistry and Immunodiagnostics Market to its store. "2014 Strategies for the Japanese
...Commenting on the news, Jennifer Cather, M D , Modern Research Associates, Dallas Texas, stated, "Results from the 52-week analysis of the ESTEEM program suggest that early responses seen with OTEZLA treatment in multiple efficacy endpoints of plaque psoriasis, including difficult to treat areas, are durable over time. Together with the observed long-term consistent safety and tolerability profile, these findings are encouraging." The full analyst notes on Celgene Corporation are available to download free of charge at:

More Content

All (116) | News (100) | Reports (0) | Blogs (13) | Audio/Video (0) | Fact Sheets (1) | Press Releases (2)
sort by: Date | Relevance
JNJ Beats Estimates, Device Sales Flat [Published QMED - 9 hours ago]
Johnson & Johnson's Management Discusses Q1 201... [Published Seeking Alpha - Apr 15 2014]
Flat sales mask busy quarter for J&J med tech biz [Published FierceMedicalDevices - Apr 15 2014]
Johnson and Johnson Beats Earnings And Revenues... [Published Bidness Etc - Apr 15 2014]
Here’s Why Johnson & Johnson Had a Crazy Good F... [Published Wall St. Cheat Sheet - Apr 15 2014]
Brazil IVD Market Analysis to 2017 - The 5th La... [Published Individual.com - Apr 15 2014]
Johnson & Johnson (JNJ) Beats Earnings Estimate... [Published Value Walk - Apr 15 2014]
Johnson & Johnson Reports 2014 First-Quarter Re... [Published PharmaceuticalProcessing - Apr 15 2014]
Blackstone’s Gates buyout one of 2014′s largest... [Published PE Hub Blog - Apr 14 2014]
Earnings Preview: Johnson & Johnson Q1 2014 [Published Seeking Alpha - Apr 11 2014]
Blackstone’s Gates buyout one of 2014′s largest... [Published PE Hub Blog - Apr 11 2014]
TRLPC: Blackstone's Gates buyout one of 2014's ... [Published Reuters - Apr 11 2014]
Pharma deals during March 2014 [Published PMLive - Apr 11 2014]
2014 France Hematology & Flow Cytometry Markets... [Published PitchEngine - Apr 08 2014]
US Point-of-Care/POC Infectious Disease Testing... [Published PitchEngine - Apr 08 2014]
Japan Clinical Chemistry & Immunodiagnostics Ma... [Published PitchEngine - Apr 07 2014]
Spain Microbiology Testing Market 2014 : Trends... [Published PitchEngine - Apr 07 2014]
US Point-of-Care/POC Diagnostic Testing Market ... [Published PitchEngine - Apr 07 2014]
US HIV/AIDS Diagnostic Testing Market 2014 : HI... [Published PitchEngine - Apr 07 2014]
Ortho-Clinical Diagnostics Inc. - Strategic SWO... [Published SBWire - Apr 07 2014]
France Transfusion Diagnostic Testing Market 20... [Published PitchEngine - Apr 07 2014]
The 5 Best-Performing Dividend Aristocrats of Q1 [Published Wyatt Investment Research - Apr 07 2014]
UK Therapeutic Drug Monitoring (TDM) Market 201... [Published PitchEngine - Apr 07 2014]
Was Selling Ortho-Clinical Diagnostics A Right ... [Published BioPortfolio - Apr 04 2014]
5 Things to Know About the 1st Quarter in Priva... [Published Preqin - Apr 03 2014]
Healthcare Companies Report Transactions, Appea... [Published Finwin - Apr 03 2014]
Is Dividend Machine Johnson & Johnson Still A Buy? [Published Investing.com - Apr 03 2014]
Is Dividend Machine Johnson & Johnson A Buy? [Published Citybizlist - Apr 03 2014]
Is Dividend Machine Johnson & Johnson A Buy? [Published BioPortfolio - Apr 03 2014]
J&J Accepts $4B Offer For Ortho-Clinical Diagno... [Published Medical Design Online - Apr 02 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Here’s Why Johnson & Johnson Had a Crazy Good F... [Published Wall St. Cheat Sheet - Apr 15 2014]
Source: http://www.flickr.com/photos/59937401@N07/ Shares of  Johnson & Johnson  ( NYSE:JNJ ) jumped as much as 1.6 percent in early trading on Tuesday after the healthcare and pharmaceutical company reported strong first-quarter results . Sales ...
Blackstone’s Gates buyout one of 2014′s largest... [Published PE Hub Blog - Apr 14 2014]
Private equity firm Blackstone (BX.N) is set to launch a $4.2 billion financing to back its $5.4 billion acquisition of auto parts maker Gates Global . The deal is the second-largest U.S. leveraged buyout financing of the year, according to Thomson ...
Blackstone’s Gates buyout one of 2014′s largest... [Published PE Hub Blog - Apr 11 2014]
(Reuters) – Private equity firm Blackstone is set to launch a $4.2 billion financing to back its $5.4 billion acquisition of auto parts maker Gates Global. The deal is the second-largest U.S. leveraged buyout financing of the year, according to ...
5 Things To Know About the 1st Quarter in Priva... [Published WSJ.com: Private Equity Beat - Apr 02 2014]
Flush with cash, private equity firms invested an increasing amount of capital during the first quarter, even as the number of deals struck fell by more than 10% compared to last quarter. Cerberus Capital Management’s $9.4 billion deal for supermarket ...
Cramer: JNJ Deal Will Lead to a Buyback and Muc... [Published TheStreet.com - YouTube - Apr 01 2014]
<a style="font-size: 15px; font-weight: bold;font-decoration: none;" href="http://www.youtube.com/watch?v=wrEjbliLPUw&feature=youtube_gdata"&gt;Cramer: JNJ Deal Will Lead to a Buyback and Much More Upside Johnson & Johnson is selling its Ortho-Clinical ...
1 2 3

Press Releases

sort by: Date | Relevance
Johnson & Johnson Announces Acceptance Of Bindi... [Published Financial Services - Mar 31 2014]
Johnson & Johnson Announces Binding Offer From ... [Published Financial Services - Jan 16 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.